Equities

Medical Ikkou Group Co Ltd

3353:TYO

Medical Ikkou Group Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)2,054.00
  • Today's Change2.00 / 0.10%
  • Shares traded500.00
  • 1 Year change-1.01%
  • Beta0.3775
Data delayed at least 20 minutes, as of Nov 15 2024 04:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Medical Ikkou Group Co Ltd grew revenues 17.71% from 33.90bn to 39.90bn while net income improved 36.89% from 759.60m to 1.04bn.
Gross margin12.30%
Net profit margin2.97%
Operating margin3.72%
Return on assets4.35%
Return on equity9.93%
Return on investment6.50%
More ▼

Cash flow in JPYView more

In 2024, Medical Ikkou Group Co Ltd increased its cash reserves by 21.37%, or 1.34bn. The company earned 4.28bn from its operations for a Cash Flow Margin of 10.72%. In addition the company generated 277.76m cash from financing while 3.22bn was spent on investing.
Cash flow per share553.31
Price/Cash flow per share4.02
Book value per share3,662.09
Tangible book value per share3,382.70
More ▼

Balance sheet in JPYView more

Medical Ikkou Group Co Ltd has a Debt to Total Capital ratio of 39.41%, a lower figure than the previous year's 49.97%.
Current ratio1.58
Quick ratio1.42
Total debt/total equity0.6797
Total debt/total capital0.3941
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 12.50% and 36.85%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Grocery) industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)1.38%
Div growth rate (5 year)2.38%
Payout ratio (TTM)14.41%
EPS growth(5 years)8.27
EPS (TTM) vs
TTM 1 year ago
57.24
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.